Early detection of symptoms using electronic patient-reported outcomes and a Fitbit to optimise care in metastatic breast cancer: study protocol of the SYMPHA trial
Therapeutic strategies for patients with metastatic breast cancer (mBC) are aimed at prolonging survival while preserving health-related quality of life (HRQoL). Current systemic therapies, however, are frequently associated with severe toxicities that impair HRQoL. Early detection of symptoms related to treatmen...